| Literature DB >> 31988387 |
Katharina Lueck1, Amanda-Jayne F Carr1, Lu Yu2, John Greenwood1, Stephen E Moss3.
Abstract
Wnt signalling mediates complex cell-cellinteractions during development and proliferation. Annexin A8 (AnxA8), a calcium-dependent phospholipid-binding protein, and canonical Wnt signalling mechanisms have both been implicated in retinal pigment epithelial (RPE) cell differentiation. The aim here was to examine the possibility of cross-talk between AnxA8 and Wnt signalling, as both are down-regulated upon fenretinide (FR)-mediated RPE transdifferentiation. AnxA8 suppression in RPE cells via siRNA or administration of FR induced neuronal-like cell transdifferentiation and reduced expression of Wnt-related genes, as measured by real-time PCR and western blotting. AnxA8 gene expression, on the other hand, remained unaltered upon manipulating Wnt signalling, suggesting Wnt-related genes to be downstream effectors of AnxA8. Co-immunoprecipitation revealed an interaction between AnxA8 and β-catenin, which was reduced in the presence of activated TGF-β1. TGF-β1 signalling also reversed the AnxA8 loss-induced cell morphology changes, and induced β-catenin translocation and GSK-3β phosphorylation in the absence of AnxA8. Ectopic over-expression of AnxA8 led to an increase in active β-catenin and GSK-3β phosphorylation. These data demonstrate an important role for AnxA8 as a regulator of Wnt signalling and a determinant of RPE phenotype, with implications for regenerative medicine approaches that utilise stem cell-derived RPE cells to treat conditions such as age-related macular degeneration.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31988387 PMCID: PMC6985107 DOI: 10.1038/s41598-020-58296-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Microarray analysis pre- and post-FR treatment.
| gene symbol | Description | fold change |
|---|---|---|
| ANXA8 | Annexin A8 | −4.63574 |
| FZD1 | Frizzled homolog 1 | −1.52405 |
| FZD4 | Frizzled homolog 4 | −1.61569 |
| WNT2B | wingless-type MMTV integration site family, member 2B | −1.44753 |
FR treatment downregulated gene expression of AnxA8, as well as Wnt signaling-related genes Frizzled-1 (FZD1), Frizzled-4 (FZD4) and Wnt2b (WNT2B) in the human ARPE19 cell line.
Figure 1AnxA8 depletion suppresses Wnt signaling (A) Real-time PCR revealed decreased expression levels of Wnt signaling–related genes after exposure to FR and AnxA8 siRNA, while GSK-3β expression was increased. Shown are mean and standard deviation of five independent experiments. (B) Western blots showing that FR as well as AnxA8 suppression results in significantly less β-catenin and active β-catenin protein in RPE cell lysates compared to controls. Quantification was performed by densitometric analysis of 4 different data sets, and expressed as mean and standard deviation. Asterisks indicate statistical significance. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 (C) Immunofluorescence staining of FR- and AnxA8 siRNA-treated RPE cells displayed loss of β-catenin (green) and active β-catenin (red) at cell-cell contact sites and in the perinuclear region. Shown are representative images of three independent experiments and higher magnification images.
Figure 2AnxA8 gene expression is not affected by Wnt signaling (A) Phase images reveal a normal ARPE-19 cell phenotype when Wnt signaling is activated or inhibited. Suppression of AnxA8 led to reduced proliferation and formation of extensions. Shown are representative images from 4 independent experiments (B) ARPE19 cells exposed to AnxA8 siRNA exhibited reduced AnxA8 gene expression, while control treatments as well as Wnt activators and inhibitor did not affect AnxA8 expression. Presented are mean and standard deviation of 4 individual data sets. Asterisks indicate statistical significance. **p ≤ 0.01 (C) AnxA8 suppression in ARPE19 cells induced a significant downregulation in AnxA8 and β-catenin, and an increase in GSK-3β. However, silencing β-catenin or GSK-3β suppressed expression of their respective genes, but did not change AnxA8 mRNA transcript levels. Illustrated are mean and standard deviation of 5 independent experiments determined by PCR. Asterisks indicate statistical significance. *p ≤ 0.05, **p ≤ 0.01.
Figure 3AnxA8 physically associates with β-catenin. (A) ARPE19 cells were subjected to immunoprecipitation with anti-AnxA8 antibody followed by immunoblotting with β-catenin and active β-catenin. Shown are representative western blots from 4 independent experiments. (B) Pre-exposure of cells to Wnt3a for 1 hour left the interaction unaltered, however, stimulation with TGF-β1 disrupted the interaction, though this was restored when counteracting TGF-β1 signaling with the Alk5 inhibitor SB431542 (INH). Experiments were repeated 3–5 times. (C) The AnxA8/β-catenin interaction decreased significantly in the presence of TGF-β1, and in a control in which AnxA8 was depleted using siRNA. Shown are representative immunoblots and the statistical values are plotted in a graph as mean and standard deviation. Significant changes are marked with asterisks. **p ≤ 0.01.
Figure 4AnxA8 depletion restricts canonical Wnt signalling. (A) Analysis of cytosolic and nuclear fractions of RPE cells revealed a decrease in β-catenin and active β-catenin protein expression as well as nuclear translocation upon AnxA8 suppression. TGF-β1 was capable of restoring β-catenin and its active form in the absence of AnxA8. GSK-3β protein levels remained unchanged, however, GSK-3β was phosphorylated in the absence of AnxA8 and more so in combination with TGF-β1. Shown are representative western blots of 4 individual experiments. (B) Densitometric analysis of the blots shown in (A). Statistics are expressed as mean and standard deviation, and asterisks indicate statistical significance. *p ≤ 0.05, **p ≤ 0.01. (C) β-catenin/active β-catenin ratio analysed from the statistical data from (B) revealed a shift towards β-catenin in nuclear fractions of AnxA8-depleted cell treated in response to Wnt3a. (D) RPE cells treated with AnxA8 siRNA revealed reduced β-catenin, AnxA8, and elevated GSK-3β mRNA transcripts analysed by PCR. TGF-β1 is partly capable of restoring β-catenin and AnxA8 expression levels in AnxA8-depleted cells. (E) Transcripts of Wnt-dependent RPE transcription factors Mitf and Otx2, as well as canonical Wnt target genes Axin1, c-myc and Lef1 were decreased upon treatment with FR or AnxA8 siRNA. Illustrated are mean and standard deviation of at least 4 separate data sets. Asterisks indicate statistical significance. *p ≤ 0.05, **p ≤ 0.01. (F) Phase images show formation of extensions and arrested proliferation in AnxA8-depleted cells. Exposure to TGF-β1 in the absence of AnxA8 resulted in relatively normal ARPE-19 cell growth. Depicted are representative images from 4 individual experiments.
Figure 5Overexpression of AnxA8 amplifies canonical Wnt signaling. (A) Western blotting reveals an increase in active β-catenin and GSK-3β protein in AnxA8-GFP transfected cells compared to controls, while β-catenin is unchanged (B) Quantification of blots such as those in A are presented as mean and standard deviation. Significant changes are marked with asterisks. *p ≤ 0.05. (C) AnxA8 overexpression in ARPE19 cells yielded increased levels of AnxA8 and slightly higher levels of GSK-3β mRNA. Addition of TGF-β1 led to increased β-catenin expression levels in AnxA8-overexpressing cells. Values are mean and standard deviation from 4 independent experiments determined by PCR. Asterisks indicate statistical significance. **p ≤ 0.01. (D) Transcripts of canonical Wnt target genes Axin1, c-myc and Lef1 were not significantly altered upon overexpression of AnxA8. Illustrated are mean and standard deviation of 4 separate data sets.
Human and porcine primer pairs used in real-time PCR.
| Target | Sequence from 5′ to 3′ | |
|---|---|---|
| human AnxA8 | F | TGG GAC CCT GAT AAG AAA CAT |
| R | TCC TGG AGA CTC TGG CTT CAT | |
| human β-Catenin | F | GCC TGC CAT CTG TGC TCT TC |
| R | ACT AGT CGT GGA ATG GCA CC | |
| human Frizzled-1 | F | ATT TGG TCA GTG CTG TGC TG |
| R | TCA TGA AGA GGA TGG TGC AG | |
| human Frizzled-4 | F | GGG CAC GAG CTG CAG ACG GAC G |
| R | GCA CCT CTT CAT CAC CTG GCC C | |
| human Wnt2b | F | CCG CTG TGG TCG CAC GGC TGT G |
| R | AGT GCC TAG GGA ACC TGC AGC C | |
| human Wnt3a | F | CTG TTG GGC CAC AGT ATT CC |
| R | ATG AGC GTG TCA CTG CAA AG | |
| human Otx2 | F | GAC CAC TTC GGG TAT GGA CT |
| R | TGG ACA AGG GGA TCT GAC AGT | |
| human Mitf | F | GTG CCA ACT TCT TTC ATC A |
| R | ACC TAA ACC GTC CAT TCA | |
| human GAPDH | F | ACC CAC TCC TCC ACC TTT G |
| R | CTC TTG TGC TCT TGC TGG G | |
| human GSK-3β | F | GCG GAG AGC TGC AAG CCG G |
| R | CTT GTG GCC TGT CTG GAC CC | |
| human Axin2 | F | ACT GCC CAC ACG ATA AGG AG |
| R | CTG GCT ATG TCT TTG GAC CA | |
| human LEF-1 | F | CTT TAT CCA GGC TGG TCT GC |
| R | TCG TTT TCC ACC ATG TTT CA | |
| human c-myc | F | CTT CTC TCC GTC CTC GGA TTC T |
| R | GAA GGT GAT CCA GAC TCT GAC CTT | |
| porcine AnxA8 | F | CCC AGA CCC CGA CGC GGA GAC C |
| R | GTT CTT GGT CCG AGA AGC CAG G | |
| porcine GAPDH | F | AAG TGG ACA TTG TCG CCA TC |
| R | TCA CAA ACA TGG GGG CAT C | |
| porcine β-Catenin | F | GCA ATG ACT CGC GCT CAG AGG |
| R | CTG AGG AGA ACG CAT GAT GGC | |
| Porcine GSK-3β | F | GGA TGG CAG CAA GGT GAC CAC |
| R | CCG GAA CAT AGT CCA GCA CCA G |
Shown are forward (F) and reverse (R) sequences of the primers.